Fusion Antibodies plc (FAB.L)
GBp 6.6
(-2.94%)
GBp 6.6
(-2.94%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.77 Million | -1.75 Million | -333 Thousand | -1.15 Million | -166 Thousand | -1.09 Million |
| Net Income | -2.22 Million | -2.59 Million | -1.2 Million | -2.89 Million | -697 Thousand | -1.26 Million |
| Depreciation & Amortization | 220 Thousand | 372 Thousand | 751 Thousand | 714 Thousand | 622 Thousand | 431.21 Thousand |
| Deferred income taxes | - | -213 Thousand | -1.39 Million | 1.76 Million | -338 Thousand | -228.52 Thousand |
| Stock-based compensation | 86 Thousand | 35 Thousand | 21 Thousand | 19 Thousand | 83 Thousand | 97.63 Thousand |
| Change in working capital | -68 Thousand | 566 Thousand | 127 Thousand | -688 Thousand | 171 Thousand | -125.73 Thousand |
| Other non-cash items | 811 Thousand | 81 Thousand | 1.36 Million | -61 Thousand | -7000.00 | -8563.00 |
| Investing Cash Flow | -2000.00 | -114 Thousand | -258 Thousand | -365 Thousand | -109 Thousand | -1.38 Million |
| Investments in PPE | -2000.00 | -114 Thousand | -258 Thousand | -365 Thousand | -109 Thousand | -1.38 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3000.00 | 3000.00 | 1000.00 | 3000.00 | 6000.00 | 5000.00 |
| Financing Cash Flow | 2.77 Million | 7000.00 | -46 Thousand | 2.66 Million | -172 Thousand | -27.66 Thousand |
| Debt repayment | -33 Thousand | -7000.00 | -162 Thousand | -150 Thousand | -172 Thousand | -36.22 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.8 Million | - | 116 Thousand | 2.81 Million | - | - |
| Other Financing Activities | -5000.00 | 14 Thousand | -55 Thousand | 2.64 Million | -184 Thousand | 8563.00 |
| Accounts receivables | 133 Thousand | 819 Thousand | -77 Thousand | -553 Thousand | 169 Thousand | -158 Thousand |
| Accounts payables | -280 Thousand | -299 Thousand | 309 Thousand | 5000.00 | 99 Thousand | 193.06 Thousand |
| Inventory | 79 Thousand | 46 Thousand | -105 Thousand | -140 Thousand | -97 Thousand | -160.85 Thousand |
| Other working capital | -280 Thousand | - | - | - | - | 62.00 |
| Cash at beginning of period | 195 Thousand | 2.04 Million | 2.68 Million | 1.53 Million | 1.98 Million | 4.49 Million |
| Cash at end of period | 1.19 Million | 195 Thousand | 2.04 Million | 2.68 Million | 1.53 Million | 1.98 Million |
| Capital Expenditure | -2000.00 | -114 Thousand | -258 Thousand | -365 Thousand | -109 Thousand | -1.38 Million |
| Effect of forex changes on cash | 2000.00 | 8000.00 | 5000.00 | - | -338.00 | -338.00 |
| Net cash flow / Change in cash | 1 Million | -1.85 Million | -637 Thousand | 1.14 Million | -447.33 Thousand | -2.5 Million |
| Free Cash Flow | -1.77 Million | -1.86 Million | -591 Thousand | -1.51 Million | -275 Thousand | -2.47 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -869 Thousand | -2.22 Million | -1.35 Million | -1.48 Million | -2.59 Million | -1.11 Million |
| Depreciation & Amortization | 95 Thousand | 220 Thousand | 125 Thousand | 124 Thousand | 372 Thousand | 248 Thousand |
| Deferred income taxes | - | - | -339 Thousand | 37 Thousand | -213 Thousand | -250 Thousand |
| Stock-based compensation | - | - | 16 Thousand | 31 Thousand | 35 Thousand | 4000.00 |
| Change in working capital | 5000.00 | -68 Thousand | -73 Thousand | 316 Thousand | 566 Thousand | 250 Thousand |
| Other non-cash items | 535 Thousand | 811 Thousand | 276 Thousand | -23 Thousand | 81 Thousand | 104 Thousand |
| Investing Cash Flow | -2000.00 | -2000.00 | 2000.00 | 244 Thousand | -114 Thousand | -358 Thousand |
| Investments in PPE | -2000.00 | -2000.00 | - | 244 Thousand | -114 Thousand | -358 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 2000.00 | 2000.00 | 3000.00 | 1000.00 |
| Financing Cash Flow | 1.13 Million | 2.77 Million | 1.64 Million | -260 Thousand | 7000.00 | 267 Thousand |
| Debt repayment | -5000.00 | -33 Thousand | -28 Thousand | -260 Thousand | -7000.00 | -267 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.13 Million | 2.8 Million | 1.67 Million | - | - | - |
| Other Financing Activities | -5000.00 | - | 1.66 Million | -257 Thousand | 14 Thousand | -7000.00 |
| Accounts receivables | -86 Thousand | 133 Thousand | 219 Thousand | 515 Thousand | 819 Thousand | 304 Thousand |
| Accounts payables | 27 Thousand | -280 Thousand | -307 Thousand | -213 Thousand | -299 Thousand | -86 Thousand |
| Inventory | 64 Thousand | 79 Thousand | 15 Thousand | 14 Thousand | 46 Thousand | 32 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 487 Thousand | 195 Thousand | 195 Thousand | 1.19 Million | 2.04 Million | 2.04 Million |
| Cash at end of period | 1.19 Million | 1.19 Million | 487 Thousand | 195 Thousand | 195 Thousand | 1.19 Million |
| Capital Expenditure | -2000.00 | -2000.00 | - | 244 Thousand | -114 Thousand | -358 Thousand |
| Effect of forex changes on cash | - | - | 193 Thousand | 8000.00 | 8000.00 | 2.04 Million |
| Net cash flow / Change in cash | 712 Thousand | 1 Million | 292 Thousand | -1 Million | -1.85 Million | -851 Thousand |
| Free Cash Flow | -421 Thousand | -1.77 Million | -1.35 Million | -751 Thousand | -1.86 Million | -1.11 Million |
CPX
0R1E
NILI
0906
600622
SCGL